Table 1.
All patients (n = 52) | |||
Gender | Female | 45 | 87% |
Male | 7 | 13% | |
Age, median (range) | 52 (27 – 81) | ||
Clinical presentation | Incidental finding | 39 | 75% |
Non-incidental | 13 | 25% | |
Size, cm, median of all tumors (range) | 0.44 (0.1 – 0.9) | ||
Size of non-incidental tumor, cm, median (range) | 0.7 (0.4 – 0.9) | ||
Sampling of the thyroid gland | Entirely sampled | 23 | 44% |
Representatively Sampled | 29 | 56% | |
Sections of thyroid sampled, mean, median (range) | 12, 10 (2 – 26) | ||
Sampling and status of lymph nodes | pNx: Not sampled | 32 | 62% |
pN0: Benign lymph node(s) N0 | 20 | 38% | |
Surgical procedure | Lobectomy | 23 | 44% |
Total thyroidectomy | 29 | 56% | |
Encapsulation | Encapsulated | 22 | 42% |
Well circumscribed | 30 | 58% | |
Other benign tumors | Adenoma | 9 | 17% |
None | 45 | 83% | |
Follow up duration, years, median (range) | 4.3 (1.0–18.1) | ||
Disease status at last follow up (FU) | No evidence of disease (NED) | 52 | 100% |
Patients with at least 2 year follow up (n = 38) | |||
Surgical procedure | Lobectomy/hemithyroidectomy | 15 | 39% |
Total thyroidectomy | 23 | 61% | |
Follow up duration, years, median (range) | 6.3 (2.0 –18.1) | ||
Disease status at last FU | NED | 38 | 100% |
Patients with at least 5 year follow up (n = 25) | |||
Surgical procedure | Lobectomy | 12 | 48% |
Total/subtotal thyroidectomy | 13 | 52% | |
Follow up duration, years, median (range) | 9.6 (5.2–18.1) | ||
Disease status at last FU | NED | 25 | 100% |
All values are expressed as N and % of column total unless otherwise specified.